João Paulo Tardivo

João Paulo Tardivo

Auto-generated profile, based on publicly available information

João Paulo Tardivo

Fundação Medicina ABC, Santo André, SP, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
JTJoão Paulo Tardivo
João Paulo Tardivo
AGAuro Del Giglio
Auro Del Giglio
COCarla Santos de Oliveira
Carla Santos de Oliveira
DGDino Santesso Gabrielli
Dino Santesso Gabrielli
HJHelena Couto Junqueira
Helena Couto Junqueira
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista

1 September 2014 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
JTJoão Paulo Tardivo
João Paulo Tardivo
FAFernando Adami
Fernando Adami
JCJoão Antonio Correa
João Antonio Correa
MPMaria Aparecida Silva Pinhal
Maria Aparecida Silva Pinhal
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista

1 August 2006 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
JTJoão P. Tardivo
João P. Tardivo
AGAuro Del Giglio
Auro Del Giglio
LPLuis H. Paschoal
Luis H. Paschoal
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista
Objective: The aim of this study was to evaluate the efficiency of photodynamic therapy (PDT) with phenotiazinium compounds (methylene blue and toluidine blue) and excitation by a non-coherent light source (RL50) to treat AIDS-related Kaposi's sarcoma (Sk-AIDS). Background Data: Sk-AIDS is a malignant disease that is recurrent in AIDS patients. Laser-based PDT protocols have been applied to treat Sk-AIDS with relative success. Methods: A single patient with multiple lesions who had undergone chemotherapy without success was treated with several applications of PDT, and the patient was closely evaluated. The PDT protocol consisted of injecting a mixture of phenotiazinium compounds into the lesions and applying RL50 at 18 J/cm 2 . Results: Complete remission with excellent cosmetic result was observed. This result was discussed in terms of the known mechanisms of PDT action and compared with other PDT protocols. Conclusion: This inexpensive PDT protocol, which is based on phenothiazinium compounds and RL50, is efficient to treat Sk-AIDS.

1 October 2011 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
DSDennis Song
Dennis Song
José Angelo Lauletta LindosoJosé Angelo Lauletta Lindoso
José Angelo Lauletta Lindoso
LOLuiza Keiko Oyafuso
Luiza Keiko Oyafuso
EKEdite Hatsumi Yamashiro Kanashiro
Edite Hatsumi Yamashiro Kanashiro
JCJoão Luiz Cardoso
João Luiz Cardoso
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista
Objective: The purpose of this study was to show the efficiency and underlying mechanism of action of photodynamic therapy (PDT) using methylene blue (MB) and non-coherent light sources to treat cutaneous leishmaniasis (CL). Background data: Systemic treatment can cause severe side effects, and PDT using porphyrin precursors as sensitizers has been used as an alternative to treat CL. MB has been used under illumination or in the dark to treat a wide range of medical conditions, and it exhibits antimicrobial activity against protozoa and viruses. Methods: In in vitro tests, the cell viability (via a MTT colorimetric assay) of Leishmania amazonensis parasites was evaluated as a function of MB concentration. In in vivo experiments, we analyzed the treatment of two lesions from a patient with leishmaniasis. The patient received a low dose of pentavalent antimony (SbV), and one lesion was treated with PDT. Results: We observed IC 50 decreases from 100 to 20 μM in response to PDT when MB was used in different concentrations in in vitro tests. Use of SbV in combination with the PDT protocol produced faster wound recovery when compared with the use of SbV alone. Conclusions: The in vitro experiments and the results from the clinical case suggest that the inexpensive PDT protocol that is based on MB and RL50® may be used to treat CL caused by L. amazonensis .

1 September 2015 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
JTJoao Paulo Tardivo
Joao Paulo Tardivo
MWMark Wainwright
Mark Wainwright
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista

1 February 2009 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
JTJoão P. Tardivo
João P. Tardivo
Mauricio  BaptistaMauricio Baptista
Mauricio Baptista
Objective: This article describes two inexpensive photodynamic antimicrobial chemotherapy (PACT) protocols to provide intensive local care on ulcerated feet of diabetic patients with osteomyelitis. Background Data: Patients with this condition generally have poor quality of life. The usual treatment consists of the administration of a cocktail of drugs including anti-inflammatories, promoters of blood circulation, and systemic antibiotics. However, depending on the conditions of the tissues, amputation may be required. Consequently, it is important to develop PACT protocols that can help avoid amputation. Materials and Methods: Two PACT protocols were applied to two diabetic patients with osteomyelitis. These protocols were based on several PACT sessions that consisted of: (1) local injection of mixtures of phenothiazines (2% in water) and Hypericum perforatum extract (10% in propylene glycol), and (2) illumination, lasting 10 min, applied to the lesion's interior and exterior using, respectively, an optical fiber and a non-coherent light source. The frequency of PACT was daily or every other day in the beginning, and weekly after tissue recovery begun. The patients were followed clinically and by radiographic testing. Results: Both PACT protocols helped cure these patients who were about to have amputation of their feet. Radiograms showed that bone had healed and that the bone's texture had improved. Conclusion: Here we have described efficient and affordable PACT protocols to treat osteomyelitis in the feet of diabetic patients. This treatment modality should be considered by vascular surgeons and by orthopedists to treat osteomyelitis that is resistant to conventional treatments.